| No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * [Number of genes] |
KEGG DRUG * |
DrugBank |
Disease ID * [Number of diseases] |
| 1 | Adherens junction 2 genes, 1 drug (DrugBank), 3 diseases shown |
[2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 2 | Alcoholism 2 genes, 4 drugs (DrugBank), 5 diseases shown |
[2] DRD1, DRD2 |
D00633 |
Dopamine |
[3] 6, 7, 74 |
| D07870 |
| [1] DRD2 |
D00780 |
Bromocriptine |
[2] 6, 74 |
| D03165 |
| D00987 |
Cabergoline |
[3] 6, 74, 75 |
| D00784 |
Ropinirole |
[3] 6, 74, 309 |
| D08489 |
| 3 | Amphetamine addiction 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] DRD1 |
D00633 |
Dopamine |
[3] 6, 7, 74 |
| D07870 |
| 4 | Bladder cancer 2 genes, 1 drug (DrugBank), 3 diseases shown |
[2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 5 | Breast cancer 4 genes, 2 drugs (DrugBank), 3 diseases shown |
[2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [2] ESR1, ESR2 |
D00962 |
Clomifene |
[1] 74 |
| D07726 |
| 6 | Calcium signaling pathway 4 genes, 2 drugs (DrugBank), 5 diseases shown |
[2] DRD1, DRD5 |
D00633 |
Dopamine |
[3] 6, 7, 74 |
| D07870 |
| [2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 7 | cAMP signaling pathway 6 genes, 5 drugs (DrugBank), 6 diseases shown |
[3] DRD1, DRD2, DRD5 |
D00633 |
Dopamine |
[3] 6, 7, 74 |
| D07870 |
| [1] DRD2 |
D00780 |
Bromocriptine |
[2] 6, 74 |
| D03165 |
| D00987 |
Cabergoline |
[3] 6, 74, 75 |
| D00784 |
Ropinirole |
[3] 6, 74, 309 |
| D08489 |
| [3] SSTR1, SSTR2, SSTR5 |
D10147 |
Pasireotide |
[3] 67, 74, 75 |
| 8 | Central carbon metabolism in cancer 2 genes, 1 drug (DrugBank), 3 diseases shown |
[2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 9 | Choline metabolism in cancer 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] EGFR |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 10 | Cocaine addiction 2 genes, 4 drugs (DrugBank), 5 diseases shown |
[2] DRD1, DRD2 |
D00633 |
Dopamine |
[3] 6, 7, 74 |
| D07870 |
| [1] DRD2 |
D00780 |
Bromocriptine |
[2] 6, 74 |
| D03165 |
| D00987 |
Cabergoline |
[3] 6, 74, 75 |
| D00784 |
Ropinirole |
[3] 6, 74, 309 |
| D08489 |
| 11 | Colorectal cancer 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] EGFR |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 12 | Cushing syndrome 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] EGFR |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 13 | Cytokine-cytokine receptor interaction 2 genes, 3 drugs (DrugBank), 19 diseases shown |
[1] GHR |
D02691 |
Somatotropin |
[18] 2, 3, 13, 19, 46, 74, 75, 78, 96, 113, 191, 193, 195, 236, 265, 274, 276, 299 |
| [1] PRL |
D00780 |
Bromocriptine |
[2] 6, 74 |
| D03165 |
| D00987 |
Cabergoline |
[3] 6, 74, 75 |
| 14 | Dopaminergic synapse 5 genes, 4 drugs (DrugBank), 5 diseases shown |
[5] DRD1, DRD2, DRD3, DRD4, DRD5 |
D00633 |
Dopamine |
[3] 6, 7, 74 |
| D07870 |
| [1] DRD2 |
D00780 |
Bromocriptine |
[2] 6, 74 |
| D03165 |
| D00987 |
Cabergoline |
[3] 6, 74, 75 |
| [3] DRD2, DRD3, DRD4 |
D00784 |
Ropinirole |
[3] 6, 74, 309 |
| D08489 |
| 15 | EGFR tyrosine kinase inhibitor resistance 2 genes, 1 drug (DrugBank), 3 diseases shown |
[2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 16 | Endocrine and other factor-regulated calcium reabsorption 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] ESR1 |
D00962 |
Clomifene |
[1] 74 |
| D07726 |
| 17 | Endocrine resistance 4 genes, 2 drugs (DrugBank), 3 diseases shown |
[2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [2] ESR1, ESR2 |
D00962 |
Clomifene |
[1] 74 |
| D07726 |
| 18 | Endocytosis 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] EGFR |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 19 | Endometrial cancer 2 genes, 1 drug (DrugBank), 3 diseases shown |
[2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 20 | Epithelial cell signaling in Helicobacter pylori infection 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] EGFR |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 21 | ErbB signaling pathway 2 genes, 1 drug (DrugBank), 3 diseases shown |
[2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 22 | Estrogen signaling pathway 3 genes, 2 drugs (DrugBank), 3 diseases shown |
[1] EGFR |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [2] ESR1, ESR2 |
D00962 |
Clomifene |
[1] 74 |
| D07726 |
| 23 | Focal adhesion 2 genes, 1 drug (DrugBank), 3 diseases shown |
[2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 24 | FoxO signaling pathway 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] EGFR |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 25 | Gap junction 3 genes, 5 drugs (DrugBank), 6 diseases shown |
[2] DRD1, DRD2 |
D00633 |
Dopamine |
[3] 6, 7, 74 |
| D07870 |
| [1] DRD2 |
D00780 |
Bromocriptine |
[2] 6, 74 |
| D03165 |
| D00987 |
Cabergoline |
[3] 6, 74, 75 |
| D00784 |
Ropinirole |
[3] 6, 74, 309 |
| D08489 |
| [1] EGFR |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 26 | Gastric acid secretion 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] SSTR2 |
D10147 |
Pasireotide |
[3] 67, 74, 75 |
| 27 | Gastric cancer 2 genes, 1 drug (DrugBank), 3 diseases shown |
[2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 28 | Glioma 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] EGFR |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 29 | GnRH secretion 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] ESR2 |
D00962 |
Clomifene |
[1] 74 |
| D07726 |
| 30 | GnRH signaling pathway 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] EGFR |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 31 | Growth hormone synthesis, secretion and action 5 genes, 2 drugs (DrugBank), 19 diseases shown |
[1] GHR |
D02691 |
Somatotropin |
[18] 2, 3, 13, 19, 46, 74, 75, 78, 96, 113, 191, 193, 195, 236, 265, 274, 276, 299 |
| [4] SSTR1, SSTR2, SSTR3, SSTR5 |
D10147 |
Pasireotide |
[3] 67, 74, 75 |
| 32 | Hepatitis C 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] EGFR |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 33 | Hepatocellular carcinoma 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] EGFR |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 34 | HIF-1 signaling pathway 2 genes, 1 drug (DrugBank), 3 diseases shown |
[2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 35 | Human cytomegalovirus infection 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] EGFR |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 36 | Human papillomavirus infection 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] EGFR |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 37 | JAK-STAT signaling pathway 3 genes, 4 drugs (DrugBank), 20 diseases shown |
[1] EGFR |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [1] GHR |
D02691 |
Somatotropin |
[18] 2, 3, 13, 19, 46, 74, 75, 78, 96, 113, 191, 193, 195, 236, 265, 274, 276, 299 |
| [1] PRL |
D00780 |
Bromocriptine |
[2] 6, 74 |
| D03165 |
| D00987 |
Cabergoline |
[3] 6, 74, 75 |
| 38 | MAPK signaling pathway 2 genes, 1 drug (DrugBank), 3 diseases shown |
[2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 39 | Melanoma 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] EGFR |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 40 | MicroRNAs in cancer 2 genes, 1 drug (DrugBank), 3 diseases shown |
[2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 41 | Morphine addiction 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] DRD1 |
D00633 |
Dopamine |
[3] 6, 7, 74 |
| D07870 |
| 42 | Neuroactive ligand-receptor interaction 12 genes, 7 drugs (DrugBank), 36 diseases shown |
[5] DRD1, DRD2, DRD3, DRD4, DRD5 |
D00633 |
Dopamine |
[3] 6, 7, 74 |
| D07870 |
| [3] DRD2, DRD3, DRD4 |
D00784 |
Ropinirole |
[3] 6, 74, 309 |
| D08489 |
| [2] DRD2, PRL |
D00780 |
Bromocriptine |
[2] 6, 74 |
| D03165 |
| D00987 |
Cabergoline |
[3] 6, 74, 75 |
| [1] GHR |
D02691 |
Somatotropin |
[18] 2, 3, 13, 19, 46, 74, 75, 78, 96, 113, 191, 193, 195, 236, 265, 274, 276, 299 |
| [1] NR3C1 |
D00292 |
Dexamethasone |
[20] 13, 16, 28, 35, 46, 53, 63, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 222, 296, 299 |
| D00975 |
| D01510 |
| D01615 |
| D01632 |
| D01948 |
| D02174 |
| D02591 |
| D02592 |
| [4] SSTR1, SSTR2, SSTR3, SSTR5 |
D10147 |
Pasireotide |
[3] 67, 74, 75 |
| 43 | Non-small cell lung cancer 2 genes, 1 drug (DrugBank), 3 diseases shown |
[2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 44 | Oxytocin signaling pathway 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] EGFR |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 45 | Pancreatic cancer 2 genes, 1 drug (DrugBank), 3 diseases shown |
[2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 46 | Parathyroid hormone synthesis, secretion and action 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] EGFR |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 47 | Parkinson disease 2 genes, 4 drugs (DrugBank), 5 diseases shown |
[2] DRD1, DRD2 |
D00633 |
Dopamine |
[3] 6, 7, 74 |
| D07870 |
| [1] DRD2 |
D00780 |
Bromocriptine |
[2] 6, 74 |
| D03165 |
| D00987 |
Cabergoline |
[3] 6, 74, 75 |
| D00784 |
Ropinirole |
[3] 6, 74, 309 |
| D08489 |
| 48 | Pathways in cancer 4 genes, 2 drugs (DrugBank), 3 diseases shown |
[2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [2] ESR1, ESR2 |
D00962 |
Clomifene |
[1] 74 |
| D07726 |
| 49 | PD-L1 expression and PD-1 checkpoint pathway in cancer 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] EGFR |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 50 | Phospholipase D signaling pathway 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] EGFR |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 51 | PI3K-Akt signaling pathway 4 genes, 4 drugs (DrugBank), 20 diseases shown |
[2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [1] GHR |
D02691 |
Somatotropin |
[18] 2, 3, 13, 19, 46, 74, 75, 78, 96, 113, 191, 193, 195, 236, 265, 274, 276, 299 |
| [1] PRL |
D00780 |
Bromocriptine |
[2] 6, 74 |
| D03165 |
| D00987 |
Cabergoline |
[3] 6, 74, 75 |
| 52 | Platinum drug resistance 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 53 | Prolactin signaling pathway 3 genes, 3 drugs (DrugBank), 3 diseases shown |
[2] ESR1, ESR2 |
D00962 |
Clomifene |
[1] 74 |
| D07726 |
| [1] PRL |
D00780 |
Bromocriptine |
[2] 6, 74 |
| D03165 |
| D00987 |
Cabergoline |
[3] 6, 74, 75 |
| 54 | Prostate cancer 2 genes, 1 drug (DrugBank), 3 diseases shown |
[2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 55 | Proteoglycans in cancer 3 genes, 2 drugs (DrugBank), 3 diseases shown |
[2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [1] ESR1 |
D00962 |
Clomifene |
[1] 74 |
| D07726 |
| 56 | Rap1 signaling pathway 2 genes, 5 drugs (DrugBank), 6 diseases shown |
[1] DRD2 |
D00780 |
Bromocriptine |
[2] 6, 74 |
| D03165 |
| D00987 |
Cabergoline |
[3] 6, 74, 75 |
| D00633 |
Dopamine |
[3] 6, 7, 74 |
| D07870 |
| D00784 |
Ropinirole |
[3] 6, 74, 309 |
| D08489 |
| [1] EGFR |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 57 | Ras signaling pathway 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] EGFR |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 58 | Regulation of actin cytoskeleton 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] EGFR |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 59 | Relaxin signaling pathway 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] EGFR |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 60 | Shigellosis 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] EGFR |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 61 | Thyroid hormone signaling pathway 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] ESR1 |
D00962 |
Clomifene |
[1] 74 |
| D07726 |
| 62 | Tight junction 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |